Showing items 1–100
Conjugates of quaternized tubulysin compounds
Grant US-11793880-B2
United States of America
Modified relaxin polypeptides and their uses
Grant US-11786578-B2
United States of America
Variant forms of urate oxidase and use thereof
Grant US-11781119-B2
United States of America
Process for the preparation of glucuronide drug-linkers and intermediates thereof
Grant US-11730822-B2
United States of America
Multi-arm polymeric alkanoate conjugates
Grant US-11672776-B2
United States of America
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of…
Grant US-11639927-B2
United States of America
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of…
Grant US-11598767-B2
United States of America
Multi-drug antibody drug conjugates
Grant US-11541128-B2
United States of America
Nucleic acids encoding modified relaxin polypeptides
Grant US-11439710-B2
United States of America
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical…
Grant US-11364281-B2
United States of America
Variant forms of urate oxidase and use thereof
Grant US-11345899-B2
United States of America
Methods of treating heart failure and fibrotic disorders using modified relaxin…
Grant US-11311605-B2
United States of America
Formulations for bovine granulocyte colony stimulating factor and variants thereof
Grant US-11273202-B2
United States of America
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
Grant US-11248031-B2
United States of America
Conjugates of quaternized tubulysin compounds
Grant US-11229708-B2
United States of America
Method of treating cardiovascular disease and heart failure with modified relaxin…
Grant US-11185570-B2
United States of America
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
Grant US-11103593-B2
United States of America
Enteric CT contrast material based on low-z atoms
Grant US-11033640-B2
United States of America
Modified FGF-21 polypeptides and their uses
Grant US-10961291-B2
United States of America
Method of treating fibroblast growth factor 21 (FGF-21) deficiency
Grant US-10874714-B2
United States of America
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of…
Grant US-10823727-B2
United States of America
Methods of treatment using modified relaxin polypeptides comprising a non-naturally…
Grant US-10751391-B2
United States of America
Variant forms of urate oxidase and use thereof
Grant US-10731139-B2
United States of America
Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain
Grant US-10702588-B2
United States of America
Non-natural amino acid replication-dependent microorganisms and vaccines
Grant US-10428333-B2
United States of America
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides…
Grant US-10377806-B2
United States of America
Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses
Grant US-10377805-B2
United States of America
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
Grant US-10266578-B2
United States of America
Therapeutic uses of modified relaxin polypeptides
Grant US-10253083-B2
United States of America
Therapeutic uses of modified FGF-21 polypeptides
Grant US-10189883-B2
United States of America
Lyophilized therapeutic peptibody formulations
Grant US-10166189-B2
United States of America
Variant forms of urate oxidase and use thereof
Grant US-10160958-B2
United States of America
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of…
Grant US-10139399-B2
United States of America
Modified bovine G-CSF polypeptides and their uses
Grant US-10138283-B2
United States of America
Multi-arm polymeric prodrug conjugates of taxane-based compounds
Grant US-10098865-B2
United States of America
Multi-arm polymeric alkanoate conjugates
Grant US-10039737-B2
United States of America
Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring…
Grant US-9975936-B2
United States of America
Method of treating heart failure with modified relaxin polypeptides
Grant US-9962450-B2
United States of America
Modified leptin polypeptides and their uses
Grant US-9938333-B2
United States of America
Variant forms of urate oxidase and use thereof
Grant US-9926537-B2
United States of America
Variant forms of urate oxidase and use thereof
Grant US-9926538-B2
United States of America
PEG-urate oxidase conjugates and use thereof
Grant US-9885024-B2
United States of America
Variant forms of urate oxidase and use thereof
Grant US-9670467-B2
United States of America
Modified animal erythropoietin polypeptides and their uses
Grant US-9644014-B2
United States of America
Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
Grant US-9631004-B2
United States of America
Therapeutic ribonucleases
Grant US-9579365-B2
United States of America
Polymer derivatives
Grant US-9574048-B2
United States of America
Therapeutic uses of modified relaxin polypeptides
Grant US-9567386-B2
United States of America
Thrombopoietic compounds
Grant US-9534032-B2
United States of America
Purification of proteins with cationic surfactant
Grant US-9534013-B2
United States of America
Methods of treatment using modified FGF-21 polypeptides comprising non-naturally…
Grant US-9517273-B2
United States of America
Multi-arm polymeric alkanoate conjugates
Grant US-9504755-B2
United States of America
Methods and compositions comprising non-natural amino acids
Grant US-9488660-B2
United States of America
Nucleic acids encoding modified relaxin polypeptides
Grant US-9452222-B2
United States of America
Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
Grant US-9434778-B2
United States of America
Non-natural ribonuclease conjugates as cytotoxic agents
Grant US-9393319-B2
United States of America
Lyophilized therapeutic peptibody formulations
Grant US-9283260-B2
United States of America
Modified human four helical bundle polypeptides and their uses
Grant US-9260472-B2
United States of America
Remodeling and glycopegylation of fibroblast growth factor (FGF)
Grant US-9200049-B2
United States of America
Methods and compositions for the treatment of cancer
Grant US-9192656-B2
United States of America
Antigen-binding polypeptides and their uses
Grant US-9175083-B2
United States of America
Modified animal erythropoietin polypeptides and their uses
Grant US-9156899-B2
United States of America
Conjugated factor VIII molecules
Grant US-9150848-B2
United States of America
Thrombopoietic compounds
Grant US-9145450-B2
United States of America
Non-natural amino acid replication-dependent microorganisms and vaccines
Grant US-9121024-B2
United States of America
Non-natural amino acid replication-dependent microorganisms and vaccines
Grant US-9121025-B2
United States of America
Modified FGF-21 polypeptides comprising non-naturally occurring amino acids
Grant US-9079971-B2
United States of America
Variant forms of urate oxidase and use thereof
Grant US-9017980-B2
United States of America
Therapeutic ribonucleases
Grant US-9006407-B2
United States of America
Modified insulin polypeptides and their uses
Grant US-8946148-B2
United States of America
Method for purifying urate oxidase tetramers and octamers
Grant US-8921064-B2
United States of America
Glycopegylated erythropoietin
Grant US-8916360-B2
United States of America
Coupling proteins to a modified polysaccharide
Grant US-8916518-B2
United States of America
Modified human four helical bundle polypeptides and their uses
Grant US-8907064-B2
United States of America
Modified human four helical bundle polypeptides and their uses
Grant US-8906676-B2
United States of America
Modified ribonucleases
Grant US-8840882-B2
United States of America
Conjugates of hydroxyalkyl starch and a protein
Grant US-8840879-B2
United States of America
Glycopegylated factor IX
Grant US-8791070-B2
United States of America
Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1]
Grant US-8791066-B2
United States of America
Human growth hormone modified at position 35
Grant US-8778880-B2
United States of America
Thrombopoietic compounds
Grant US-8748571-B2
United States of America
Relaxin polypeptides comprising non-naturally encoded amino acids
Grant US-8735539-B2
United States of America
Compositions and methods for ribonuclease-based therapeutics
Grant US-8697062-B2
United States of America
Non-natural ribonuclease conjugates as cytotoxic agents
Grant US-8697065-B2
United States of America
Glycopegylated factor IX
Grant US-8632770-B2
United States of America
Therapeutic ribonucleases
Grant US-8628768-B2
United States of America
Hasylated polypeptides
Grant US-8618266-B2
United States of America
PEG-urate oxidase conjugates and use thereof
Grant US-8618267-B2
United States of America
Thrombopoietic compounds
Grant US-8618044-B2
United States of America
Modified animal erythropoietin polypeptides and their uses
Grant US-8569233-B2
United States of America
Variant forms of urate oxidase and use thereof
Grant US-8541205-B2
United States of America
Hydroxyalkyl starch derivatives
Grant US-8475765-B2
United States of America
Non-natural ribonuclease conjugates as cytotoxic agents
Grant US-8470315-B2
United States of America
Variant form of urate oxidase and use thereof
Grant US-8465735-B2
United States of America
Coupling low-molecular substances to a modified polysaccharide
Grant US-8466277-B2
United States of America
Suppressor tRNA transcription in vertebrate cells
Grant US-8420792-B2
United States of America
Glycopegylated factor IX
Grant US-8404809-B2
United States of America
Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine…
Grant US-8383365-B2
United States of America
Human ribonuclease for use in prevention and treatment of cancer; antitumor agents
Grant US-8298801-B2
United States of America
Showing items 1–100